富血小板血在治疗雄性发育性脱发症中的有效性:全面评估
Rúben Lopes-Silva1, Maria Santos1, Maria Luísa Sequeira2
1Department of Maxillofacial Surgery, Unidade Local de Saúde de São José, Lisbon, PRT.
Cureus
|February 13, 2025
概括
富于血小板的血 (PRP) 通过增加头发密度和厚度来治疗雄性发 (AGA) 是有前途的. 标准化PRP的制备和应用对于在脱发治疗中获得一致,有效的结果至关重要.
科学领域:
- 再生医学是一种再生医学.
- 皮肤病学 皮肤病学
- 修复头发科学 修复头发科学
背景情况:
- 富血小板血 (PRP) 含有有利于毛囊活动的生长因子.
- 雄激素性脱发症 (AGA) 是一种常见的脱发形式,有各种治疗选择.
- 在PRP研究中不一致的结果需要对其对AGA的疗效进行审查.
研究的目的:
- 评估PRP在治疗雄激素性脱发症 (AGA) 的整体有效性.
- 综合关于PRP疗效的最新证据,考虑不同的制备和应用方法.
主要方法:
- 在PubMed的系统文献搜索中,寻找关于PRP和AGA的研究.
- 包括2020年1月至2024年5月期间发表的11项研究.
- 分析重点是与安慰剂或其他治疗方法相比PRP的疗效,以及各种PRP配方/输送方法.
主要成果:
- 大多数研究表明,PRP有效地增加了AGA患者的头发密度和厚度.
- 一般观察到PRP的积极影响,尽管由于不同的方案,结果有所不同.
- 组合疗法 (例如,PRP与微针或米诺克西迪尔) 显示出增强的疗效.
结论:
- 在AGA中,PRP是增加头发密度和厚度的一种可行的治疗选择.
- 为了获得一致的结果,需要对PRP制备和应用方法进行标准化.
- 未来的研究应该完善协议,并探索组合疗法,以最大限度地提高疗效.
关键词:
一个又一个又一个的 aga aga.雄性激素性脱发症 (androgenetic alopecia) 是一种导致人脱发的疾病.发毛囊是毛囊中的一个.富有血小板血的血.这就是为什么prp prp.更多相关视频
08:34Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
Published on: February 24, 2021
2.4K
07:51Effects of Allogeneic Platelet-Rich Plasma PRP on the Healing Process of Sectioned Achilles Tendons of Rats: A Methodological Description
Published on: March 19, 2018
9.2K
相关概念视频
Formation of the Platelet Plug
3.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.9K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
145
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
145
Clot Retraction and Fibrinolysis
3.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.5K
